Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
December 18, 2012
Tumor microenvironment and myeloid-derived suppressor cells
Viktor Umansky, Alexandra Sevko
Cancer Immunology, Immunotherapy : CII
|
November 29, 2011
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
Viktor Umansky, Alexandra Sevko
Pigment Cell & Melanoma Research
|
April 9, 2013
Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells
Viktor Umansky, Alexandra Sevko
Journal of Cancer
|
February 7, 2013
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves
Alexandra Sevko, Viktor Umansky
Seminars in Cancer Biology
|
February 22, 2012
Melanoma-induced immunosuppression and its neutralization
Viktor Umansky, Alexandra Sevko
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 30, 2014
Myeloid-derived suppressor cells in malignant melanoma
Viktor Umansky, Alexandra Sevko, Christoffer Gebhardt, et al.
Engineering Biology
|
October 30, 2024
Programmable cancer treatments: Engineering biology approaches for living cures
Marc Biarnes Carrera, Alexandra Sevko, Nicholas Glanville, et al.
Journal of Immunotoxicology
|
January 31, 2012
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner
Tillmann Michels, Galina V Shurin, Hiam Naiditch, et al.
Hepatology (Baltimore, Md.)
|
January 26, 2017
The Linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis
Yutaka Shimizu, Nieves Peltzer, Alexandra Sevko, et al.
Journal of Immunotoxicology
|
March 28, 2012
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice
Alexandra Sevko, Veronika Kremer, Christine Falk, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
December 18, 2012
Tumor microenvironment and myeloid-derived suppressor cells
Viktor Umansky, Alexandra Sevko
Cancer Immunology, Immunotherapy : CII
|
November 29, 2011
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation
Viktor Umansky, Alexandra Sevko
Pigment Cell & Melanoma Research
|
April 9, 2013
Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells
Viktor Umansky, Alexandra Sevko
Journal of Cancer
|
February 7, 2013
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves
Alexandra Sevko, Viktor Umansky
Seminars in Cancer Biology
|
February 22, 2012
Melanoma-induced immunosuppression and its neutralization
Viktor Umansky, Alexandra Sevko
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 30, 2014
Myeloid-derived suppressor cells in malignant melanoma
Viktor Umansky, Alexandra Sevko, Christoffer Gebhardt, et al.
Engineering Biology
|
October 30, 2024
Programmable cancer treatments: Engineering biology approaches for living cures
Marc Biarnes Carrera, Alexandra Sevko, Nicholas Glanville, et al.
Journal of Immunotoxicology
|
January 31, 2012
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner
Tillmann Michels, Galina V Shurin, Hiam Naiditch, et al.
Hepatology (Baltimore, Md.)
|
January 26, 2017
The Linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis
Yutaka Shimizu, Nieves Peltzer, Alexandra Sevko, et al.
Journal of Immunotoxicology
|
March 28, 2012
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice
Alexandra Sevko, Veronika Kremer, Christine Falk, et al.
Page
of 3